
Pfizer’s Talzenna (talazoparib) has secured FDA approval, it has emerged. The poly (ADP-ribose) polymerase (PARP) inhibitor is now set to …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland

